Copyright (c) 2013 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=anthLatest Financial News for Anthera Pharmaceuticals, Inc.en-USThu, 13 Jun 2013 03:01:19 GMThttp://l.yimg.com/a/i/brand/purplelogo/uh/us/fin.gifhttp://finance.yahoo.com/q/h?s=anth14445http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/130613/anth8-k.htmlyahoo_finance/3528299395Thu, 13 Jun 2013 03:01:19 GMThttp://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125llb4hb/*http://www.noodls.com/view/83E7ECB02F93D5006D2AE8C340A0A8A8023B1AB3[at noodls] - HAYWARD, Calif., June 12, 2013/PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced the appointment of May Liuas its Senior Vice President, Finance and Administration. In this position, ...yahoo_finance/2286360824Wed, 12 Jun 2013 22:15:19 GMThttp://us.rd.yahoo.com/finance/external/theflyonthewall/rss/SIG=13vfs1ebc/*http://www.theflyonthewall.com/permalinks/entry.php/ANTHid1845798/ANTH-Anthera-Pharmaceuticals-CFO-to-leave-the-company-June-yahoo_finance/1748414375Wed, 12 Jun 2013 20:42:46 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/anthera-pharmaceuticals-announces-personnel-changes-203000118.html[PR Newswire] - HAYWARD, Calif., June 12, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced the appointment of May Liu as its Senior Vice President, Finance and Administration. In this ...yahoo_finance/3757593790Wed, 12 Jun 2013 20:30:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/anthera-pharmaceuticals-present-annual-jefferies-190000807.html[PR Newswire] - HAYWARD, Calif., May 31, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, ...yahoo_finance/3140704800Fri, 31 May 2013 19:00:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=anthyahoo_finance/919660733Tue, 21 May 2013 17:04:12 GMThttp://us.rd.yahoo.com/finance/external/xtrsa/rss/SIG=13vbgb3j9/*http://seekingalpha.com/article/1448541-anthera-pharmaceuticals-management-discusses-q1-2013-results-earnings-call-transcript?source=yahoo[at Seeking Alpha] - Anthera Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcriptyahoo_finance/2609599241Mon, 20 May 2013 23:20:05 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/130517/anth8-k.htmlyahoo_finance/1430046902Fri, 17 May 2013 12:37:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/anthera-pharmaceuticals-reports-2013-first-212200980.html[PR Newswire] - HAYWARD, Calif., May 13, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended March 31 st , 2013. First Quarter ...yahoo_finance/2900111193Mon, 13 May 2013 21:22:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/130513/anth10-q.htmlyahoo_finance/1520797567Mon, 13 May 2013 13:01:59 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20130513.html?t=anthyahoo_finance/2159866598Mon, 13 May 2013 11:07:06 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/anthera-pharmaceuticals-announces-additional-data-203000962.html[PR Newswire] - HAYWARD, Calif., May 7, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, today ...yahoo_finance/3008152943Tue, 07 May 2013 20:30:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/anthera-announces-first-quarter-2013-180000105.html[PR Newswire] - HAYWARD, Calif., May 3, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, will ...yahoo_finance/3690084599Fri, 03 May 2013 18:00:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/anthera-refinances-existing-debt-20-214500380.html[PR Newswire] - HAYWARD, Calif., April 5, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced ...yahoo_finance/2185016385Fri, 05 Apr 2013 21:45:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/130405/anth8-k.htmlyahoo_finance/7898542Fri, 05 Apr 2013 14:22:10 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/anths-blisibimod-enters-phase-iii-220326660.htmlyahoo_finance/3918360183Mon, 01 Apr 2013 22:03:26 GMThttp://us.rd.yahoo.com/finance/external/xwscheats/rss/SIG=135c8mhpo/*http://wallstcheatsheet.com/stocks/4-healthcare-stock-stories-for-weekend-investment-wellness.html/?ref=YFyahoo_finance/2412321290Thu, 28 Mar 2013 19:30:04 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/130328/anth8-k.htmlyahoo_finance/2089525990Thu, 28 Mar 2013 11:03:36 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/anthera-initiates-chablis-sc1-phase-201500895.html[PR Newswire] - HAYWARD, Calif., March 27, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune ...yahoo_finance/3845746464Wed, 27 Mar 2013 20:15:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/anthera-pharmaceuticals-reports-2012-fourth-201500862.html[PR Newswire] - HAYWARD, Calif., March 26, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter and fiscal year ended December 31, ...yahoo_finance/737192312Tue, 26 Mar 2013 20:15:00 GMT